Abstract
Lymphedema after cancer treatment is a progressive, debilitating condition that is becoming increasingly common as mortality rates decline. The purpose of this review is to summarize the evolution of treatment of lymphedema focusing on surgical management and outcomes. With the development of supermicrosurgical techniques and advanced imaging technology, surgical treatment of lymphedema has evolved past reductive measures and sought to address the underlying pathophysiology. Particularly in breast cancer-related lymphedema, our group follows a novel algorithm to address both the autologous breast reconstruction with physiologic treatment of the affected extremity. Patients and physicians alike should be educated about the risk factors for developing lymphedema after cancer treatment, prompt and proper diagnosis, as well as conservative and surgical treatment options. While the optimal treatment algorithm remains to be elucidated, a multi-modality treatment approach has demonstrated promising outcomes in symptom improvement, volume reduction, and quality of life.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have